Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Insulin independence among patients with diabetes utilizing a PPI in combination with an immune tolerance agent

Insulin independence among patients with diabetes utilizing a PPI in combination with an immune tolerance agent

US Patent 8808689 · Granted Aug 19, 2014

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Insulin independence among patients with diabetes utilizing an optimized hamster2018
Insulin independence among patients with diabetes utilizing an optimized hamster2018
Insulin independence among patients with diabetes utilizing an optimized hamster2018
Insulin independence among patients with diabetes utilizing an optimized hamster2018
Insulin independence among patients with diabetes utilizing an optimized hamster2018
Generation of new pancreatic beta cells2016
Insulin independence among patients with diabetes utilizing an optimized hamster2016
Generation of new pancreatic beta cells2015
Generation of new pancreatic beta cells2014
Peptides, derivatives and analogs thereof, and methods of using same2014
Compositions and methods of using proislet peptides and analogs thereof2014
Methods and compositions relating to islet cell neogenesis2014